Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
1,084
Price
$13.10
Total Value
$14,200.40
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Jun 10, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 12, 2026 |
| Shares Purchased | 1,084 |
| Price per Share | $13.10 |
| Total Value | $14,200.40 |
| Shares Owned After | 51,776 |
| Derivative | No |
| Accession Number | 0001918845-26-000018 |
| Document | View SEC Filing |